Regulations.gov document
Draft Guidance for Industry on Patient Counseling Information Section of Labeling for…
Other · FDA-2013-D-1067 · posted Sep 18, 2013
Key facts
| Document ID | FDA-2013-D-1067-0002 |
|---|---|
| Title | Draft Guidance for Industry on Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products--Content and Format |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2013-D-1067 |
| Posted | Sep 18, 2013 |
| Comment period opens | Sep 18, 2013 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: